Lumosa Therapeutics Co., Ltd. (6535.TWO)
TWD 191.0
(-1.29%)
TWD 191.0
(-1.29%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 56.91 Million | 26.64 Million | 17.36 Million | 21.65 Million | 172.04 Million |
| Cost of Revenue | 15.43 Million | 12.08 Million | 7.47 Million | 8.49 Million | 67.21 Million |
| Gross Profit | 41.48 Million | 14.56 Million | 9.88 Million | 13.15 Million | 104.82 Million |
| Operating Expenses | 41.48 Million | 320.48 Million | 440.16 Million | 354.71 Million | 254.78 Million |
| Selling, General and Administrative Expenses | 47.8 Million | 40.02 Million | 34.12 Million | 37.66 Million | 42.6 Million |
| Research and Development Expenses | 369.3 Million | 280.45 Million | 406.04 Million | 317.04 Million | 212.18 Million |
| Other Expenses | - | -203.69 Million | 523.02 Million | 15.72 Million | - |
| Cost and Expenses | 432.54 Million | 332.56 Million | 447.64 Million | 363.2 Million | 322 Million |
| Operating Income | -375.62 Million | -504.29 Million | 96.2 Million | -322.41 Million | -149.96 Million |
| Interest Expense | 47 Thousand | 149 Thousand | 260 Thousand | 151 Thousand | 271 Thousand |
| Income Tax Expense | 248 Thousand | 36 Thousand | - | - | 14.68 Million |
| Earnings before Tax | -250.08 Million | -504.44 Million | 95.94 Million | -322.56 Million | -226.25 Million |
| Net Income | -238.04 Million | -494.66 Million | 95.94 Million | -322.56 Million | -240.93 Million |
| Earnings Per Share Basic | -1.47 | -3.05 | 0.64 | -2.67 | -2.05 |
| Earnings Per Share Diluted | -1.47 | -3.05 | 0.64 | -2.67 | -2.05 |
| Weighted Average Shares Outstanding | 161.93 Million | 162.4 Million | 150.64 Million | 120.81 Million | 117.76 Million |
| Weighted Average Shares Outstanding (Diluted) | 162.44 Million | 162.4 Million | 150.91 Million | 120.81 Million | 117.76 Million |
| Gross Margin | 0.73 | 0.55 | 0.57 | 0.61 | 0.61 |
| EBIT Margin | -3.98 | -18.10 | 7.39 | -13.25 | -0.64 |
| Profit Margin | -4.18 | -18.57 | 5.53 | -14.90 | -1.40 |
| EBITDA | -226.67 Million | -482.13 Million | 128.3 Million | -286.78 Million | -186.64 Million |
| Earnings Before Tax Margin | -6.60 | -18.93 | 5.54 | -14.89 | -0.87 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 8.51 Million | 4.46 Million | 18.46 Million | 56.91 Million | 16.26 Million | 14.2 Million |
| Cost of Revenue | 3.51 Million | 3.08 Million | 3.78 Million | 15.43 Million | 2.24 Million | 2.86 Million |
| Gross Profit | 5 Million | 1.37 Million | 14.68 Million | 41.48 Million | 14.02 Million | 11.34 Million |
| Operating Expenses | 78.11 Million | 82.09 Million | 122.25 Million | 417.1 Million | 101.14 Million | 119.68 Million |
| Selling, General and Administrative Expenses | 9.7 Million | 13 Million | 15.8 Million | - | 10.2 Million | 10.66 Million |
| Research and Development Expenses | 68.41 Million | 69.09 Million | 106.45 Million | - | 90.93 Million | 109.02 Million |
| Other Expenses | 136.1 Million | -38.23 Million | -15.15 Million | 115.25 Million | -38.41 Million | -45.81 Million |
| Cost and Expenses | 81.62 Million | 85.18 Million | 126.03 Million | 432.54 Million | 103.38 Million | 122.54 Million |
| Operating Income | -73.11 Million | -117.4 Million | -119.52 Million | -249.88 Million | -123.47 Million | -150.86 Million |
| Interest Expense | 54 Thousand | 39 Thousand | 4000.00 | 47 Thousand | 9000.00 | 14 Thousand |
| Income Tax Expense | -1.68 Million | -1.97 Million | -7.02 Million | 248 Thousand | 248 Thousand | -1.55 Million |
| Earnings before Tax | 65.63 Million | -117.59 Million | -119.52 Million | -250.08 Million | -122.01 Million | -152.5 Million |
| Net Income | 67.32 Million | -115.61 Million | -112.5 Million | -238.04 Million | -119.91 Million | -150.95 Million |
| Earnings Per Share Basic | 0.41 | -0.71 | -0.69 | - | -0.74 | -0.92 |
| Earnings Per Share Diluted | 0.41 | -0.71 | -0.69 | - | -0.74 | -0.92 |
| Weighted Average Shares Outstanding | 162.45 Million | 162.45 Million | 162.45 Million | 162.44 Million | 162.05 Million | 164.07 Million |
| Weighted Average Shares Outstanding (Diluted) | 162.45 Million | 162.45 Million | 162.45 Million | 162.44 Million | 162.05 Million | 164.07 Million |
| Gross Margin | 0.59 | 0.31 | 0.80 | 0.73 | 0.86 | 0.80 |
| EBIT Margin | -8.34 | -25.84 | -6.14 | - | -7.22 | -10.23 |
| Profit Margin | 7.91 | -25.91 | -6.09 | -4.18 | -7.37 | -10.63 |
| EBITDA | -70.99 Million | -115.3 Million | -113.31 Million | - | -117.39 Million | -145.31 Million |
| Earnings Before Tax Margin | -8.59 | -26.31 | -6.47 | -4.39 | -7.59 | -10.62 |
AU
9302
AZS
PNBK
000066
RAFI